4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Protara Therapeutics, Inc. (TARA) operates in the Biotechnology industry and is headquartered in New York, United States with about 46 employees. Its market capitalization is roughly $236 million. In the fiscal year ended 2025-12-31, TARA reported $0M in revenue and ($57M) in net income.
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($64M) | ($49M) | ($44M) | ($38M) | — |
| Net Income | ($57M) | ($45M) | ($40M) | ($66M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($20M) | ($19M) | ($15M) | ($17M) | ($14M) |
| Net Income | ($18M) | ($17M) | ($13M) | ($15M) | ($12M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $210M | $182M | $79M | $113M | — |
| Total Liabilities | $13M | $14M | $11M | $11M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TARA viewer.
About TickerBase · Data methodology & sources